Mannose-6-phosphate/insulin-like growth factor II receptor expression and tumor development
- PMID: 16779663
- DOI: 10.1007/s10540-006-9002-3
Mannose-6-phosphate/insulin-like growth factor II receptor expression and tumor development
Abstract
The mannose-6-phosphate/insulin-like growth factor II receptor (M6P/IGF-IIR) is a multi-functional transmembrane glycoprotein whose major function is to bind and transport M6P-bearing glycoproteins from the trans-Golgi network or the cell surface to lysosomes. The cell surface M6P/IGF-IIR also bind and internalizes the insulin-like growth factor II. The receptor gene is considered a "candidate" tumor suppressor gene. The phenotypic consequences of loss of M6P/IGF-IIR through somatic mutation are potentially very complex since M6P/IGF-IIR has a number of roles in cellular physiology. Loss of function mutations in M6P/IGF-IIR gene could contribute to multi-step carcinogenesis. In the light of the multi-functional cellular potential roles of the M6P/IGF-IIR the purpose of this review is to highlight some recent data concerning its normal functions and the potential role of its loss in tumor pathophysiology with the aim to try to clarify the possible underlying mechanisms of its involvement in tumor development.
Similar articles
-
The insulin-like growth factor-II/mannose-6-phosphate receptor: structure, distribution and function in the central nervous system.Brain Res Brain Res Rev. 2004 Mar;44(2-3):117-40. doi: 10.1016/j.brainresrev.2003.11.002. Brain Res Brain Res Rev. 2004. PMID: 15003389 Review.
-
Altered ligand binding by insulin-like growth factor II/mannose 6-phosphate receptors bearing missense mutations in human cancers.Cancer Res. 1999 Sep 1;59(17):4314-9. Cancer Res. 1999. PMID: 10485478
-
Insulin-like growth factor-2/mannose-6 phosphate receptors.Vitam Horm. 2009;80:667-97. doi: 10.1016/S0083-6729(08)00624-9. Vitam Horm. 2009. PMID: 19251055 Review.
-
Cellular distribution of insulin-like growth factor-II/mannose-6-phosphate receptor in normal human brain and its alteration in Alzheimer's disease pathology.Neurobiol Aging. 2006 Feb;27(2):199-210. doi: 10.1016/j.neurobiolaging.2005.03.005. Epub 2005 Apr 9. Neurobiol Aging. 2006. PMID: 16399207
-
Mannose-6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) in carcinogenesis.Cancer Lett. 2010 Mar 1;289(1):11-22. doi: 10.1016/j.canlet.2009.06.036. Epub 2009 Jul 30. Cancer Lett. 2010. PMID: 19646808 Review.
Cited by
-
Insulin-like growth factor II receptor-mediated intracellular retention of cathepsin B is essential for transformation of endothelial cells by Kaposi's sarcoma-associated herpesvirus.J Virol. 2007 Aug;81(15):8050-62. doi: 10.1128/JVI.00249-07. Epub 2007 May 16. J Virol. 2007. PMID: 17507477 Free PMC article.
-
Expression of small leucine-rich extracellular matrix proteoglycans biglycan and lumican reveals oral lichen planus malignant potential.Clin Oral Investig. 2018 Mar;22(2):1071-1082. doi: 10.1007/s00784-017-2190-3. Epub 2017 Aug 4. Clin Oral Investig. 2018. PMID: 28779221
-
Insulin-Like Growth Factor-2 Is Induced Following 5-Aminolevulinic Acid-Mediated Photodynamic Therapy in SW620 Human Colon Cancer Cell Line.Int J Mol Sci. 2015 Oct 2;16(10):23615-29. doi: 10.3390/ijms161023615. Int J Mol Sci. 2015. PMID: 26445041 Free PMC article.
-
Inhibition of insulin-like growth factor II (IGF-II)-dependent cell growth by multidentate pentamannosyl 6-phosphate-based ligands targeting the mannose 6-phosphate/IGF-II receptor.Oncotarget. 2016 Sep 20;7(38):62386-62410. doi: 10.18632/oncotarget.11493. Oncotarget. 2016. PMID: 27694692 Free PMC article.
-
Glycosylation shapes the efficacy and safety of diverse protein, gene and cell therapies.Biotechnol Adv. 2023 Oct;67:108206. doi: 10.1016/j.biotechadv.2023.108206. Epub 2023 Jun 22. Biotechnol Adv. 2023. PMID: 37354999 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources